Q3 2018 Holdings
Filed 2018-11-13 | 212 holdings | $297.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Align Technology, Inc.(ALGN) | Common | 016255101 | $4.4M | 11,244 | 1.5% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $4.7M | 65,714 | 1.6% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.8M | 351,618 | 1.6% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $4.9M | 192,000 | 1.7% |
| Cellectis SA(CLLS) | Sponsored ADR | 15117K103 | $7.9M | 278,988 | 2.6% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $9.6M | 272,400 | 3.2% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $11.0M | 126,176 | 3.7% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $13.6M | 140,538 | 4.6% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $14.8M | 85,755 | 5.0% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $17.1M | 444,991 | 5.8% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $46.5M | 492,078 | 15.7% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $138.3M | 391,402 | 46.5% |